Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle
about
Erythrocyte-derived ATP and perfusion distribution: role of intracellular and intercellular communicationRegulation of increased blood flow (hyperemia) to muscles during exercise: a hierarchy of competing physiological needsA selective phosphodiesterase 3 inhibitor rescues low PO2-induced ATP release from erythrocytes of humans with type 2 diabetes: implication for vascular controlImpaired skeletal muscle blood flow control with advancing age in humans: attenuated ATP release and local vasodilation during erythrocyte deoxygenationRole of erythrocyte-released ATP in the regulation of microvascular oxygen supply in skeletal muscle.Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids.Phosphodiesterase 5 inhibitors augment UT-15C-stimulated ATP release from erythrocytes of humans with pulmonary arterial hypertensionErythrocytes as controllers of perfusion distribution in the microvasculature of skeletal muscle.Regulation of blood flow distribution in skeletal muscle: role of erythrocyte-released ATP.Regulation of red blood cell deformability is independent of red blood cell-nitric oxide synthase under hypoxia.Toward a multiscale description of microvascular flow regulation: o(2)-dependent release of ATP from human erythrocytes and the distribution of ATP in capillary networks.Liposomal delivery of a phosphodiesterase 3 inhibitor rescues low oxygen-induced ATP release from erythrocytes of humans with type 2 diabetes.Synergistic effects of prostacyclin analogs and phosphodiesterase inhibitors on cyclic adenosine 3',5' monophosphate accumulation and adenosine 3'5' triphosphate release from human erythrocytes.Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin.
P2860
Q24598135-EB2C7462-5D47-4A57-B441-2294E2D4DA7CQ27001180-50DB1D9A-A7A1-4A99-B6C3-D6A5F3983CCAQ35601360-A8122E6B-A708-463E-B514-995118D95C63Q36086617-FAE765AD-0E4D-439C-AA5B-0A812D8976F4Q36535827-80F1F6E2-87A9-43FB-BCF8-654CE8BD16C6Q36990411-E3CFE2ED-5601-4EE2-961E-17B4F59B3755Q37070945-085774BC-B9F8-485C-BCFC-413542A2DB33Q37781833-D7FF3912-0BCB-42A6-B668-9695FF8A33DBQ38010153-F3C55812-8C46-45C0-9553-6A2C18DAE7F7Q39987782-2E576C6E-DA78-4933-8BE1-81C258A67CBDQ42321513-F9E714D4-BAF3-47F8-A2DB-7F11B0478D12Q43499334-CCCF7773-850E-4D14-98FC-73E751DCF361Q44499510-95D64D95-1E80-4A21-8E81-D12F41AEC941Q48238409-8C3A2871-BA78-4768-A78C-CAAA0EF846BCQ50463857-211FF813-FE7D-4B4B-B0DF-74A386481E9D
P2860
Divergent effects of low-O(2) tension and iloprost on ATP release from erythrocytes of humans with type 2 diabetes: implications for O(2) supply to skeletal muscle
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Divergent effects of low-O
@nl
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@ast
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@en
type
label
Divergent effects of low-O
@nl
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@ast
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@en
prefLabel
Divergent effects of low-O
@nl
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@ast
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@en
P2093
P2860
P1476
Divergent effects of low-O(2) ...... O(2) supply to skeletal muscle
@en
P2093
Alan H Stephenson
David Achilleus
Elizabeth A Bowles
Mary L Ellsworth
Randy S Sprague
P2860
P304
P356
10.1152/AJPHEART.00430.2010
P577
2010-05-28T00:00:00Z